Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
News

Safety data shows pacing system offers no MRI-related complications

Medtronic : 01 September, 2008  (Company News)
Initial safety and efficacy data relating to the Medtronic investigational EnRhythm MRI SureScan Pacing System shows promise for a potential solution for patients receiving their first pacemaker and needing an MRI scan.
Results presented showed no MRI-related complications, and no arrhythmia or asystole (absence of electrical activity in the heart) during MRI scans conducted on patients as part of a worldwide clinical study. Additionally, other study endpoints showing that the heart responded appropriately to the level of electrical stimulation it received from the device were met. A small number of patients experienced Implant complications consistent with rates for other pacemaker Implant procedures, but none were related to the MRI technology.

The trial is a prospective, randomized, controlled, unblinded, multi-centre study, involving 470 individuals; eligibility is based on the clinical indication for pacemaker implantation and a willingness and ability to undergo elective MRI scanning. All patients in the trial will receive an investigational EnRhythm MRI SureScan pacing system (consisting of the dual chamber EnRhythm MRI SureScan pacemaker and CapSureFix MRI SureScan pacing leads, Model 5086MRI), and two-thirds of the participants will receive MRI scans; the first MRI scans will occur approximately two to three months after device implant.

The study will compare the electrical system performance, among patients in both groups. In addition, the study will assess the MRI-related complication rates in the month following the MRI scans. The expected study duration and follow up time is approximately 30 months.

“MRI is unmatched and irreplaceable in the diagnosis of cancer and neurological disorders,” said Prof Dr Torsten Sommer, chief of the cardiovascular section of the radiology department, University of Bonn, Germany, and European lead radiology investigator for the clinical trial. “And for investigation of the brain and spinal cord, there is simply no suitable alternative in most cases. As the necessity for MRI grows, it is critical to introduce a solution that allows pacemaker patients safe access to MRI.”

“This data is promising,” continued Prof Sommer. “While the trial is ongoing, we’ve observed no lead-performance issues or unexpected MRI effects in this patient group to date.” The clinical trial will include up to 470 patients at 53 centers in Europe, the Middle East, Canada and the USA.

“Pacemaker technology has extended the lives of millions of patients since Medtronic founder Earl Bakken invented the first battery-operated pacemaker more than 50 years ago,” said Pat Mackin, senior vice president, Medtronic, and president of the Cardiac Rhythm Disease Management business. “Today we are building pacemakers and other devices from the ground up to ensure they meet the increasingly complex medical needs of today’s patients.”

Approximately two million Europeans have implanted pacemakers, but these patients are prohibited from receiving Magnetic resonance imaging (MRI) scans, a widely practiced diagnostic method for many common diseases and conditions, because their device could interact with MRI machines, potentially affecting the device or patient safety. According to Medtronic estimates, up to 50 percent of patients worldwide with implanted cardiac devices are expected to need an MRI scan during the lifetime of their devices.
Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProHealthServiceZone.com
Netgains Logo